RAY1225
A Study of RAY1225 in Participants With Obesity
Guangdong Raynovent Biotech Co · Phase 2 · Recruiting · Enrollment 270
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| RAY1225 (cohort 1) | n/r | n/r | n/r | n/r |
| Placebo (cohort 1) | n/r | n/r | n/r | n/r |
| RAY1225 (cohort 2) | n/r | n/r | n/r | n/r |
| Placebo (cohort 2) | n/r | n/r | n/r | n/r |
Not shown
- RAY1225 (cohort 1): endpoint not reported
- Placebo (cohort 1): endpoint not reported
- RAY1225 (cohort 2): endpoint not reported
- Placebo (cohort 2): endpoint not reported